TL;DR: Aetna, a CVS Health company, modified CPB 0646 governing voice therapy coverage, effective December 9, 2025. Billing teams using CPT 92507 and 92508 need to verify each claim ties to a covered indication before submitting.
Aetna's voice therapy coverage policy under CPB 0646 Aetna draws a hard line between medically necessary voice restoration and what it considers cosmetic or recreational voice improvement. The two billable CPT codes under this policy—92507 for individual treatment and 92508 for group treatment—are covered only when documentation supports one of nine specific medical indications. If your notes don't clearly connect the diagnosis to the covered list, expect a claim denial.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Voice Therapy — CPB 0646 |
| Policy Code | CPB 0646 |
| Change Type | Modified |
| Effective Date | December 9, 2025 |
| Impact Level | Medium |
| Specialties Affected | Speech-Language Pathology, Otolaryngology (ENT), Oncology (laryngeal cancer), Neurology |
| Key Action | Audit active voice therapy authorizations and confirm each patient's documented diagnosis maps to a covered CPB 0646 indication before billing CPT 92507 or 92508 |
Aetna Voice Therapy Coverage Criteria and Medical Necessity Requirements 2025
Aetna's voice therapy coverage policy is built around a single functional standard: the therapy must work to restore a patient's ability to produce speech sounds from the larynx. That word—restore—is doing a lot of work here. It rules out voice improvement, voice training, and voice modification from the jump.
For a claim billed under CPT 92507 or 92508 to meet medical necessity, the patient's diagnosis must fall into one of these nine categories:
| # | Covered Indication |
|---|---|
| 1 | Essential voice tremor |
| 2 | Surgery or traumatic injury to the vocal cords |
| 3 | Laryngeal (glottic) carcinoma treatment |
| 4 | Muscle tension dysphonia (functional dysphonia) |
| 5 | Paradoxical vocal cord motion |
| 6 | Post-laryngectomy (esophageal speech production) |
| 7 | Spastic (spasmodic) dysphonia |
| 8 | Symptomatic benign vocal fold lesions — cysts, nodules, and polyps |
| 9 | Vocal cord paralysis |
This is a defined, closed list. If the patient's condition isn't on it, the claim won't survive review.
The policy doesn't mention a blanket prior authorization requirement for voice therapy, but your individual plan contracts may impose one. Check your specific Aetna plan agreements before assuming prior auth isn't needed — especially for post-laryngectomy cases and spasmodic dysphonia, which often draw additional utilization management scrutiny.
On the reimbursement side, maintenance therapy is a key exposure point. Aetna will not reimburse ongoing treatment when the patient has stopped improving. The policy sets a concrete checkpoint: if no meaningful clinical benefit appears after four weeks, the treatment plan must be re-evaluated. Further sessions are not covered unless the patient shows documented, measurable progress.
Aetna Voice Therapy Exclusions and Non-Covered Indications
Three categories are explicitly not medically necessary under this coverage policy. Know them cold, because they show up in denial letters.
Voice quality improvement is excluded. This is different from functional restoration. If a patient wants a stronger, clearer, or more pleasant voice but doesn't have a qualifying medical condition, Aetna won't cover it.
Occupational and recreational voice use is excluded. Public speakers, singers, teachers, and performers don't qualify under CPB 0646—regardless of how professionally important their voice is. This is a clear-cut exclusion, not a gray area.
Self-limited conditions like acute laryngitis are excluded. Laryngitis resolves on its own. Aetna's position is that therapy for conditions expected to clear without intervention isn't medically necessary.
Two indications are classified as experimental and investigational — meaning Aetna considers their effectiveness unproven:
| # | Excluded Procedure |
|---|---|
| 1 | Pre-operative voice therapy to improve surgical outcomes for benign vocal fold lesions |
| 2 | Vocal fold motion impairment following chemotherapy |
These are worth flagging for your billing team, especially if you work with oncology practices. Voice therapy after chemotherapy may seem clinically appropriate, but Aetna won't cover it under this policy. Don't bill CPT 92507 or 92508 for these indications expecting payment. If your clinical team believes a patient needs therapy for one of these reasons, document the clinical rationale carefully and be prepared for a denial and appeal process.
One more item billing teams get wrong: megaphones and amplification devices like ChatterVox are not covered durable medical equipment under this policy. Aetna's definition of DME requires illness or injury as the basis for the device. An amplifier for a patient with a healthy larynx doesn't meet that bar.
For laryngectomized patients using an electronic artificial larynx, that device is covered — but as a prosthetic, not under this voice therapy CPB. Route those claims correctly and reference CPB 0437 and CPB 0560 as appropriate.
Coverage Indications at a Glance
| Indication | Coverage Status | Primary Billing Codes | Notes |
|---|---|---|---|
| Essential voice tremor | Covered | CPT 92507, 92508 | Must show functional improvement |
| Post-surgical or traumatic vocal cord injury | Covered | CPT 92507, 92508 | Document surgical or trauma event |
| Laryngeal (glottic) carcinoma | Covered | CPT 92507, 92508 | Following treatment; tie to oncology records |
| Muscle tension dysphonia (functional dysphonia) | Covered | CPT 92507, 92508 | Functional diagnosis — document clearly |
| Paradoxical vocal cord motion | Covered | CPT 92507, 92508 | May require specialist confirmation |
| Post-laryngectomy (esophageal speech) | Covered | CPT 92507, 92508 | Electronic larynx covered as prosthetic under CPB 0437 |
| Spastic (spasmodic) dysphonia | Covered | CPT 92507, 92508 | High utilization management scrutiny — document closely |
| Symptomatic benign vocal fold lesions (cysts, nodules, polyps) | Covered | CPT 92507, 92508 | Must be symptomatic, not incidental finding |
| Vocal cord paralysis | Covered | CPT 92507, 92508 | Document etiology and functional impact |
| Voice quality improvement (no underlying condition) | Not Covered | N/A | Cosmetic/elective — not medically necessary |
| Occupational or recreational voice use | Not Covered | N/A | Public speaking, singing, performance excluded |
| Acute laryngitis | Not Covered | N/A | Self-limited condition |
| Pre-op voice therapy for benign vocal fold lesion surgery | Experimental | N/A | Effectiveness not established per Aetna |
| Vocal fold motion impairment post-chemotherapy | Experimental | N/A | Effectiveness not established per Aetna |
| Voice feminization or masculinization (transgender) | Not Covered | N/A | Considered cosmetic; see CPB 0615 |
| Megaphone / amplifier devices (no illness or injury) | Not Covered (DME) | N/A | Does not meet Aetna's DME definition |
Aetna Voice Therapy Billing Guidelines and Action Items 2025
The December 9, 2025 effective date has passed. These actions apply now.
| # | Action Item |
|---|---|
| 1 | Audit active voice therapy cases in your Aetna book. Pull every open authorization or ongoing claim for CPT 92507 and 92508. Confirm each patient's documented diagnosis maps to one of the nine covered indications. If it doesn't, stop billing and flag for clinical review. |
| 2 | Review four-week progress checkpoints. Aetna's policy requires a treatment plan re-evaluation if no clinical benefit appears by week four. Build a workflow that flags cases at the four-week mark. Your documentation at that point should show specific, measurable improvement — not just continued treatment. |
| 3 | Separate voice therapy from maintenance treatment in your notes. "Maintenance" is Aetna's trigger word for denial. Your therapy notes need to show active, meaningful progress. Vague language like "patient continues to work on voice" will not hold up. Use objective measures and specific functional milestones. |
| 4 | Confirm your diagnosis coding connects clearly to a covered indication. Muscle tension dysphonia, spasmodic dysphonia, and paradoxical vocal cord motion are all covered — but only if your ICD-10 codes and clinical notes match. A mismatched diagnosis code is a fast path to a claim denial. Your billing guidelines should include a crosswalk between the nine covered indications and their corresponding ICD-10 codes. |
| 5 | Flag transgender voice therapy cases before billing. Aetna explicitly excludes voice feminization and masculinization therapy as cosmetic and not medically necessary under this policy. These claims will deny. If your practice sees patients seeking this care, set documentation and billing routing expectations before submitting anything to Aetna. |
| 6 | Route laryngectomy-related device claims correctly. Electronic artificial larynx devices for laryngectomized patients are covered as prosthetics — not under CPB 0646. If you're billing Aetna for these devices, use the prosthetic pathway and reference CPB 0437. Billing them as voice therapy will create claim denial issues and slow reimbursement. |
| 7 | Check your plan contracts for prior authorization requirements. CPB 0646 doesn't mandate prior auth at the policy level, but individual Aetna plan agreements vary. If you're seeing denials for voice therapy that look authorization-related, pull the specific plan contract. If you're unsure how this applies to your plan mix, talk to your compliance officer before submitting additional claims. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Voice Therapy Under CPB 0646
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 92507 | CPT | Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual |
| 92508 | CPT | Treatment of speech, language, voice, communication, and/or auditory processing disorder; group, two or more |
These are the two codes your billing team will use for voice therapy sessions. Both require documentation supporting a covered indication and demonstrated patient progress.
Key ICD-10-CM Codes
The policy data does not publish specific ICD-10-CM codes in its code tables. Build your own crosswalk using the nine covered clinical indications listed in the policy summary. Standard diagnosis codes for conditions like spasmodic dysphonia (G24.4), vocal cord paralysis (J38.00–J38.02), and benign vocal fold lesions (J38.1) should align with your internal billing guidelines and any Aetna plan-specific requirements. Confirm your crosswalk with your compliance officer.
Get the Full Picture for CPT 92507
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.